Article Versions Notes

Imterat M, Harter P, Rhiem K, Heitz F, Schneider S, Concin N, Moubarak M, Welz J, Vrentas V, Traut A, et al. Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients. Cancers. 2023; 15(9):2534. https://doi.org/10.3390/cancers15092534

Imterat, Majdi, Philipp Harter, Kerstin Rhiem, Florian Heitz, Stephanie Schneider, Nicole Concin, Malak Moubarak, Julia Welz, Vasileios Vrentas, Alexander Traut, and et al. 2023. "Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients" Cancers 15, no. 9: 2534. https://doi.org/10.3390/cancers15092534

Imterat, M., Harter, P., Rhiem, K., Heitz, F., Schneider, S., Concin, N., Moubarak, M., Welz, J., Vrentas, V., Traut, A., Hahnen, E., Schmutzler, R., du Bois, A., & Ataseven, B. (2023). Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients. Cancers, 15(9), 2534. https://doi.org/10.3390/cancers15092534